The synthesis and preliminary pharmacological evaluation of a series of substituted 4-phenoxypropyl analogues of the atypical antipsychotic clozapine

Australian Journal of Chemistry

Volumn 63, Issue 1, 2010, Pages 116-124

  Capuano, Ben ^a   Crosby, Ian T ^a   McRobb, Fiona M ^a   Podloucka, Anna ^a   Taylor, David A ^a   Vom, Amelia ^a   Yuriev, Elizabeth ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPSYCHOTIC AGENTS; AROMATIC RINGS; BIOCHEMICAL EFFECTS; CLOZAPINE; DIAZEPINE; ELECTRON-DONATING SUBSTITUENTS; ELECTRONWITHDRAWING; IN-VITRO; IN-VIVO; NEW SERIES; PHARMACOLOGICAL ACTIVITY; PHARMACOLOGICAL EFFECTS; RECEPTOR BINDING; RING SUBSTITUENTS; STRUCTURAL CHARACTERIZATION; SUBSTITUTED PHENOL; TARGET COMPOUND;

LEAD COMPOUNDS; PHENOLS; SYNTHESIS (CHEMICAL);

COMPLEXATION;

EID: 76849113749     PISSN: 00049425     EISSN: None     Source Type: Journal    
DOI: 10.1071/CH09345     Document Type: Article

References (30)

1. B. Capuano, I.T. Crosby, E. J. Lloyd,D.A.Taylor,Aust. J. Chem. 2002, 55, 565. doi:10.1071/CH02093 (Pubitemid 35361262)
2. J. Kane, G. Honigfeld, J. Singer, H. Meltzer, Arch. Gen. Psychiatry 1988, 45, 789.
3. J. M. Alvir, J. A. Lieberman, A. Z. Safferman, J. L. Schwimmer, J. A. Schaaf, N. Engl. J. Med. 1993, 329, 162. doi:10.1056/NEJM199307153290303 (Pubitemid 23195736)
4. Z. C. Liu, J. P. Uetrecht, J. Pharmacol. Exp. Ther. 1995, 275, 1476.
5. A. P. Holstein, C. H. Chen, Am. J. Psychiatry 1965, 122, 462.
6. B. Capuano, I.T. Crosby, E. J. Lloyd,A. Podloucka, D. A.Taylor,Aust. J. Chem. 2008, 61, 930. doi:10.1071/CH08307
7. F. H. L. Awouters, P. J. Lewi, Arzneimittelforschung 2007, 57, 625.
8. P. Seeman, H. H. M. Van Tol, Trends Pharmacol. Sci. 1994, 15, 264. doi:10.1016/0165-6147(94)90323-9 (Pubitemid 24210734)
9. B. Costall, D. H. Fortune, R. J. Naylor, V. Nohria, Eur. J. Pharmacol. 1980, 66, 207. doi:10.1016/0014-2999(80)90144-2 (Pubitemid 10043280)
10. B. Costall, R. J. Naylor, V. Nohria, Br. J. Pharmacol. 1978, 63, 381P.
11. B. Costall, R. J. Naylor, V. Nohria, Eur. J. Pharmacol. 1978, 50, 39. doi:10.1016/0014-2999(78)90251-0 (Pubitemid 9202912)
12. B. Costall, R. J. Naylor, V. Nohria, Br. J. Pharmacol. 1980, 68, 175P.
13. J. A. K. Howard,V. J.Hoy,D. O'Hagan, G.T. Smith,Tetrahedron 1996, 52, 12613. doi:10.1016/0040-4020(96)00749-1 (Pubitemid 26295489)
14. H. E. Gottlieb,V.Kotlyar,A. Nudelman, J. Org. Chem. 1997, 62, 7512. doi:10.1021/JO971176V
15. K. H. Baggaley, E. A.Watts, EP 49060 1982.
16. P. E. Gagnon, G. Nadeau, R. Cote, Can. J. Chem. 1952, 30, 592. doi:10.1139/V52-071
17. E. A. Lunney, S. E. Hagen, J. M. Domagala, C. Humblet, J. Kosinski, B. D.Tait, J. S.Warmus, M.Wilson, D. Ferguson, J. Med. Chem. 1994, 37, 2664. doi:10.1021/JM00043A006
18. T.Hogberg, G. Bondesson,N. E. Stjernstrom,Acta Pharm. Suec. 1977, 14, 149.
19. S. K. Thompson, J. S. Frazee, L. S. Kallander, C. Ma, J. P. Marino, M. J. Neeb, A. Bhat, J. J. Mcatee, R. A. Stavenger, WO 2003082205 2003.
20. B. Jones, J. Chem. Soc. 1935, 1831. doi:10.1039/JR9350001831
21. F. C. Copp, H. F. Hodson, US 3099599 1963.
22. P. E. Gagnon, J. L. Boivin, J. Giguere, Can. J. Res. B 1950, 28B, 352.
23. N. J. Leonard, W. C. Wildman, J. Am. Chem. Soc. 1949, 71, 3089. doi:10.1021/JA01177A042
24. T. Irikura, K. Nishino, M. Kitagawa, H. Uchida, N. Ichinoseki, G. Shishido, JP 19650306 1968.
25. J. C. Pascal, S. Beranger, H. Pinhas, A. Poizot, J. P. Desiles, J. Med. Chem. 1985, 28, 647. doi:10.1021/JM50001A019 (Pubitemid 15098171)
26. Y. L. Bennani, L. A. Black, W. J. Dwight, R. Faghih, R. G. Gentles, H. Liu, K. M. Phelan, A. Vasudevan, H. Q. Zhang, WO 2001066534 2001.
27. F. Ueda, T. Ozaki, K. Nakamura,WO 9604914 1996.
28. T. Fex, K. G. Olsson, A. L. Abramo, E. G. Christensson,WO 8604584 1986.
29. B. Capuano, I.T. Crosby, E. J. Lloyd,A. Podloucka, D. A.Taylor,Aust. J. Chem. 2003, 56, 875. doi:10.1071/CH03030
30. N. A. Moore, M. S. Axton, Eur. J. Pharmacol. 1990, 178, 195. doi:10.1016/0014-2999(90)90475-L